Frequently Asked Questions
The market is segmented based on , By Product Type (Self-Monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices), Distribution Channel (Retail, Online), End User (Hospital, Clinics, Diagnostic Centers, Home Healthcare, Others) – Industry Trends and Forecast to 2030.
.
The Global Glucose Monitoring Devices Market size was valued at USD 12.70 USD Billion in 2022.
The Global Glucose Monitoring Devices Market is projected to grow at a CAGR of 8.5% during the forecast period of 2023 to 2030.
The major players operating in the market include DiaMonTech AG, Abbott, GlySens ,orporated, Novo Nordisk A/S, Nemaura, PHC Holdings Corporation, TaiDoc Technology Corporation, AgaMatrix, Dexcom , ACON Laboratories , Ascensia Diabetes Care Holdings AG, Bayer AG, F. Hoffmann-La Roche Ltd, Insulet Corporation, Ypsomed AG,.
The market report covers data from the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
